interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Alectinib Hydrochloride

Generic competition · all medicines · read 12 November 2026

Is there a generic of Alectinib Hydrochloride, and who makes it?

Alectinib Hydrochloride appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Alectinib Hydrochloride1 dosage-form group in the Orange Book
0generic makers listed
  1. Alectinib Hydrochloride appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Capsule, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Alecensa. No generic is listed as marketed.

2015202020252030203501brand 2015data datePatent 9440922 listed to expire 9 June 2030Patent 9126931 listed to expire 29 May 2031Patent 9365514 listed to expire 4 March 2032Patent 10350214 listed to expire 24 April 2035Patent 11433076 listed to expire 24 April 2035Exclusivity I-947 to 18 April 2027Exclusivity ODE-477 to 18 April 2031
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 18 April 2027Exclusivity I-947 Alecensa
  • 18 April 2031Exclusivity ODE-477 Alecensa
  • 9 June 2030Patent 9440922 drug product
  • 29 May 2031Patent 9126931 drug substance
  • 4 March 2032Patent 9365514 drug product
  • 24 April 2035Patent 10350214 drug product
  • 24 April 2035Patent 11433076 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.